UBIO
Proshares UltraPro NASDAQ Biotechnology
UBIO
UBIO
Delisted
UBIO was delisted on the 27th of March, 2020.
2 hedge funds and large institutions have $2.06M invested in Proshares UltraPro NASDAQ Biotechnology in 2015 Q3 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
2
Holders Change
–
Holders Change %
0%
% of All Funds
0.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
–
Closed
2
Calls
$91K
Puts
–
Net Calls
+$91K
Net Calls Change
+$91K
Top Buyers
| 1 |
BAMS
Bellevue Asset Management (Switzerland)
Kuesnacht,
Switzerland
|
+$2.04M |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$17K |
Top Sellers
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
-$4K |
| 2 |
Morgan Stanley
New York
|
-$2K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
BAMS
1
Bellevue Asset Management (Switzerland)
Kuesnacht,
Switzerland
| $2.04M | +$2.04M | +7,000 | New |
|
|
2
UBS Group
Zurich,
Switzerland
| $17K | +$17K | +390 | New |
|
|
TRCT
3
Tower Research Capital (TRC)
New York
| – | -$4K | -40 | Closed |
|
|
4
Morgan Stanley
New York
| – | -$2K | -17 | Closed |
|